Editor's Note: Any reference to TheStreet Ratings and its underlying recommendation does not reflect the opinion of TheStreet, Inc. or any of its contributors including Jim Cramer or Stephanie Link.
) pushed the Health Care sector lower today making it today's featured Health Care laggard. The sector as a whole closed the day up 1.2%. By the end of trading, Santarus fell $1.08 (-4.3%) to $24.15 on average volume. Throughout the day, 1,474,785 shares of Santarus exchanged hands as compared to its average daily volume of 1,460,900 shares. The stock ranged in price between $24.05-$24.78 after having opened the day at $24.62 as compared to the previous trading day's close of $25.23. Other companies within the Health Care sector that declined today were:
), down 43.4%,
), down 9.3%,
), down 7.0% and
), down 5.8%.
- EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass
Santarus, Inc., a specialty biopharmaceutical company, engages in acquiring, developing, and commercializing proprietary products that address the needs of patients treated by physician specialists. Santarus has a market cap of $1.6 billion and is part of the drugs industry. Shares are up 126.4% year to date as of the close of trading on Wednesday. Currently there are 4 analysts that rate Santarus a buy, no analysts rate it a sell, and none rate it a hold.
TheStreet Ratings rates
. The company's strengths can be seen in multiple areas, such as its robust revenue growth, largely solid financial position with reasonable debt levels by most measures, notable return on equity, solid stock price performance and impressive record of earnings per share growth. Although no company is perfect, currently we do not see any significant weaknesses which are likely to detract from the generally positive outlook.
- You can view the full Santarus Ratings Report.
On the positive front,
), up 25.5%,
), up 20.8%,
), up 15.4% and
), up 13.0% , were all gainers within the health care sector with
) being today's featured health care sector leader.
- Use our health care section to find sector-relevant news.
- Or find some new ideas from our top rated stocks lists.
For investors not wanting singular stock exposure, ETFs may be of interest. Investors who are bullish on the health care sector could consider
) while those bearish on the health care sector could consider
- Find other investment ideas from our top rated ETFs lists.